Type 2 Diabetes Study Trials
Type 2 diabetes (T2D) is a chronic condition where the body doesn't use insulin properly, leading to elevated blood sugar levels over time. It affects millions of adults and often shows up alongside related conditions like obesity, hypertension, and cardiovascular disease.
Current treatments help many patients work toward improving glycemic control, but a large share still struggle to reach their goals or avoid diabetes-related complications as the disease progresses. Type 2 diabetes study trials advance new treatment options and improve outcomes for patients living with the condition.
RDI's experience in type 2 diabetes clinical studies
With over 30 years of experience, Remington-Davis (RDI) is a trusted leader in type 2 diabetes clinical research. As a research site and clinical trial management partner, we've conducted studies spanning glycemic control, cardiometabolic comorbidities, and weight management in T2D patients, working closely with sponsors, CROs, and investigators to manage high-quality studies that fuel advancement.
Our T2D trial experience includes studies enrolling patients with elevated A1C levels, as well as patients managing type 2 diabetes alongside hypertension, cardiovascular disease, and a history of stroke or heart attack. We've also supported studies focused on weight loss outcomes for patients with T2D, reflecting how closely glycemic control and weight management are linked in modern diabetes care.
Each study is led by an experienced principal investigator with deep expertise in endocrinology and metabolic disease, ensuring patients receive rigorous, expert oversight throughout their participation.
Backed by a patient-centric approach, we strive to make trial participation as comfortable and convenient as possible. We offer flexible scheduling, transportation services, and a 7,500-square-foot facility equipped with at-home amenities like Wi-Fi, beverages, snacks, and more. Details like these help us maintain a 96% patient retention rate.
At RDI, we're committed to advancing type 2 diabetes research while fostering a supportive, patient-centered experience, because better trials mean better treatments for everyone. Be a part of our next medical breakthrough.
Frequently asked questions about type 2 diabetes study trials
Each study sets its own criteria based on factors like A1C level, current medications, and any related conditions such as obesity or hypertension. Our team reviews a participant's medical history against these criteria during screening and works closely with each person's healthcare providers to confirm they're a good fit for a given study.
Researchers evaluate by monitoring participants closely throughout the trial, tracking side effects, lab values, and changes in blood glucose over time. Many studies also assess cardiovascular health and kidney function, since these outcomes matter as much as glucose control for people with type 2 diabetes. This data is reviewed at every phase before a treatment can move forward.
No, our clinical team works alongside your existing healthcare providers. We share relevant updates about your participation so your regular care team stays informed, and you can continue routine care throughout the trial.
Not anymore. While blood glucose remains a core measure, many current trials also track cardiovascular health, kidney function, and weight, since these outcomes are closely linked to long-term health in people with type 2 diabetes. Sponsors increasingly design studies to capture this fuller picture.
Once you meet the eligibility criteria, our team walks you through informed consent, answers any questions about the study design, and schedules your first visit. From there, you'll follow a structured visit schedule where our clinical team monitors your safety and progress throughout participation.
